why choose us

First received: December 12, 2022

Clinical Trial: Drug-Drug Interaction Study of Pacritinib and CYP450,Transporter Substrates, and CYP450 3A4 in Healthy Male Subjects

Study Status: ACTIVE_NOT_RECRUITING

Recruit Status: ACTIVE_NOT_RECRUITING

Condition: Drug Interactions

Study Type: INTERVENTIONAL


Official Title: Drug-Drug Interaction Study of Multiple Doses of Pacritinib and CYP450 and, Transporter Substrates, and CYP450 3A4 Inducers and Inhibitors

Brief Summary: This is a Phase 1, open-label, fixed-sequence, 2-part DDI study.Subjects will participate in only 1 study part.

Read more